Human cytomegalovirus latency alters the cellular secretome, inducing cluster of differentiation (CD)4+ T-cell migration and suppression of effector function

Proceedings of the National Academy of Sciences of the United States of America

Volumn 109, Issue 36, 2012, Pages 14538-14543

  Mason, Gavin M ^a   Poole, Emma ^a   Sissons, J G Patrick ^a   Wills, Mark R ^a   Sinclair, John H ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Herpesvirus; Immune evasion

Indexed keywords

CHEMOATTRACTANT; CHEMOKINE; CYTOKINE;

ARTICLE; CD4+ T LYMPHOCYTE; CYTOMEGALOVIRUS; CYTOTOXICITY; EFFECTOR CELL; HELPER CELL; HOST PARASITE INTERACTION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE MIGRATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; SUPERNATANT; SUPPRESSOR CELL; VIRUS LATENCY;

CD4-POSITIVE T-LYMPHOCYTES; CELL MOVEMENT; CHEMOKINE CCL8; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; GENE EXPRESSION REGULATION; HUMANS; MODELS, BIOLOGICAL; VIRUS LATENCY;

HERPESVIRIDAE; HUMAN HERPESVIRUS 5;

EID: 84865968749     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1204836109     Document Type: Article

References (40)

1. Avdic S, Cao JZ, Cheung AK, Abendroth A, Slobedman B (2011) Viral interleukin-10 expressed by human cytomegalovirus during the latent phase of infection modulates latently infected myeloid cell differentiation. J Virol 85:7465-7471.
2. Bego M, Maciejewski J, Khaiboullina S, Pari G, St Jeor S (2005) Characterization of an antisense transcript spanning the UL81-82 locus of human cytomegalovirus. J Virol 79:11022-11034. (Pubitemid 41170643)
3. Goodrum F, Jordan CT, Terhune SS, High K, Shenk T (2004) Differential outcomes of human cytomegalovirus infection in primitive hematopoietic cell subpopulations. Blood 104:687-695. (Pubitemid 38970561)
4. Goodrum F, Reeves M, Sinclair J, High K, Shenk T (2007) Human cytomegalovirus sequences expressed in latently infected individuals promote a latent infection in-vitro. Blood 110:937-945. (Pubitemid 47267432)
5. Cheung AK, Abendroth A, Cunningham AL, Slobedman B (2006) Viral gene expression during the establishment of human cytomegalovirus latent infection in myeloid progenitor cells. Blood 108:3691-3699. (Pubitemid 44864546)
6. Froberg MK (2004) Review: CMV escapes!. Ann Clin Lab Sci 34:123-130.
7. Dumortier J, et al. (2008) Human cytomegalovirus secretome contains factors that induce angiogenesis and wound healing. J Virol 82:6524-6535. (Pubitemid 351875129)
8. Fiorentini S, et al. (2011) Human cytomegalovirus productively infects lymphatic endothelial cells and induces a secretome that promotes angiogenesis and lymphangiogenesis through interleukin-6 and granulocyte-macrophage colony-stimulating factor. J Gen Virol 92:650-660.
9. Sinclair J (2008) Human cytomegalovirus: Latency and reactivation in the myeloid lineage. J Clin Virol 41:180-185.
10. Slobedman B, Mocarski ES (1999) Quantitative analysis of latent human cytomegalovirus. J Virol 73:4806-4812. (Pubitemid 29246740)
11. Stern JL, Slobedman B (2008) Human cytomegalovirus latent infection of myeloid cells directs monocyte migration by up-regulating monocyte chemotactic protein-1. J Immunol 180:6577-6585.
12. Reeves MB, Sinclair JH (2010) Analysis of latent viral gene expression in natural and experimental latency models of human cytomegalovirus and its correlation with histone modifications at a latent promoter. J Gen Virol 91:599-604.
13. Chan G, Nogalski MT, Yurochko AD (2009) Activation of EGFR on monocytes is required for human cytomegalovirus entry and mediates cellular motility. Proc Natl Acad Sci USA 106:22369-22374.
14. Jafferji I, Bain M, King C, Sinclair JH (2009) Inhibition of epidermal growth factor receptor (EGFR) expression by human cytomegalovirus correlates with an increase in the expression and binding of Wilms' Tumour 1 protein to the EGFR promoter. J Gen Virol 90:1569-1574.
15. Baggiolini M, Dewald B, Moser B (1997) Human chemokines: An update. Annu Rev Immunol 15:675-705. (Pubitemid 27169296)
16. Bettini M, Vignali DA (2009) Regulatory T cells and inhibitory cytokines in autoimmunity. Curr Opin Immunol 21:612-618.
17. Huh MI, Chang Y, Jung JC (2009) Temporal and spatial distribution of TGF-beta isoforms and signaling intermediates in corneal regenerative wound repair. Histol Histopathol 24:1405-1416.
18. Warrington K, Hillarby MC, Li C, Letarte M, Kumar S (2005) Functional role of CD105 in TGF-beta1 signalling in murine and human endothelial cells. Anticancer Res 25(3B): 1851-1864. (Pubitemid 40904577)
19. Gorelik L, Flavell RA (2002) Transforming growth factor-beta in T-cell biology. Nat Rev Immunol 2:46-53. (Pubitemid 37328775)
20. Letterio JJ (2000) Murine models defi ne the role of TGF-beta as a master regulator of immune cell function. Cytokine Growth Factor Rev 11:81-87.
21. Gorelik L, Constant S, Flavell RA (2002) Mechanism of transforming growth factor beta-induced inhibition of T helper type 1 differentiation. J Exp Med 195:1499-1505. (Pubitemid 34602827)
22. Baran J, Kowalczyk D, Ozóg M, Zembala M (2001) Three-color flow cytometry detection of intracellular cytokines in peripheral blood mononuclear cells: Comparative analysis of phorbol myristate acetate-ionomycin and phytohemagglutinin stimulation. Clin Diagn Lab Immunol 8:303-313. (Pubitemid 32217061)
23. Katial RK, Sachanandani D, Pinney C, Lieberman MM (1998) Cytokine production in cell culture by peripheral blood mononuclear cells from immunocompetent hosts. Clin Diagn Lab Immunol 5:78-81. (Pubitemid 28062951)
24. Hegde NR, et al. (2005) Endogenous human cytomegalovirus gB is presented efficiently by MHC class II molecules to CD4+ CTL. J Exp Med 202:1109-1119.
25. Spector DJ, Yetming K (2010) UL84-independent replication of human cytomegalovirus strain TB40/E. Virology 407:171-177.
26. Goodrum FD, Jordan CT, High K, Shenk T (2002) Human cytomegalovirus gene expression during infection of primary hematopoietic progenitor cells: A model for latency. Proc Natl Acad Sci USA 99:16255-16260. (Pubitemid 35462782)
27. Dziurzynski K, et al. (2011) Glioma-associated cytomegalovirus mediates subversion of the monocyte lineage to a tumor propagating phenotype. Clin Cancer Res 17:4642-4649.
28. Sung JL, Lin JT, Gorham JD (2003) CD28 co-stimulation regulates the effect of transforming growth factor-beta1 on the proliferation of naïve CD4+ T cells. Int Immunopharmacol 3:233-245. (Pubitemid 36183382)
29. Thomas DA, Massagué J (2005) TGF-beta directly targets cytotoxic T cell functions during tumor evasion of immune surveillance. Cancer Cell 8:369-380.
30. Park HY, Wakefield LM, Mamura M (2009) Regulation of tumor immune surveillance and tumor immune subversion by tgf-Beta. Immune Netw 9:122-126.
31. Del Prete G, et al. (1993) Human IL-10 is produced by both type 1 helper (Th1) and type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation and cytokine production. J Immunol 150:353-360. (Pubitemid 23133609)
32. Brady MT, MacDonald AJ, Rowan AG, Mills KH (2003) Hepatitis C virus non-structural protein 4 suppresses Th1 responses by stimulating IL-10 production from monocytes. Eur J Immunol 33:3448-3457. (Pubitemid 37541123)
33. Sabat R, et al. (2010) Biology of interleukin-10. Cytokine Growth Factor Rev 21:331-344.
34. Nachtwey J, Spencer JV (2008) HCMV IL-10 suppresses cytokine expression in monocytes through inhibition of nuclear factor-kappaB. Viral Immunol 21:477-482.
35. Cheung AK, et al. (2009) The role of the human cytomegalovirus UL111A gene in down-regulating CD4+ T-cell recognition of latently infected cells: Implications for virus elimination during latency. Blood 114:4128-4137.
36. Poole E, McGregor Dallas SR, Colston J, Joseph RS, Sinclair J (2011) Virally induced changes in cellular microRNAs maintain latency of human cytomegalovirus in CD34+ progenitors. J Gen Virol 92:1539-1549.
37. Griffin C, et al. (2005) Characterization of a highly glycosylated form of the human cytomegalovirus HLA class I homologue gpUL18. J Gen Virol 86:2999-3008. (Pubitemid 41555564)
38. Reeves MB, Lehner PJ, Sissons JG, Sinclair JH (2005) An in vitro model for the regulation of human cytomegalovirus latency and reactivation in dendritic cells by chromatin remodelling. J Gen Virol 86:2949-2954. (Pubitemid 41555558)
39. Waller EC, Day E, Sissons JG, Wills MR (2008) Dynamics of T cell memory in human cytomegalovirus infection. Med Microbiol Immunol (Berl) 197:83-96.
40. Elkington R, et al. (2004) Cross-reactive recognition of human and primate cytomegalovirus sequences by human CD4 cytotoxic T lymphocytes specific for glycoprotein B and H. Eur J Immunol 34:3216-3226. (Pubitemid 39549400)